Fellowship · Los Angeles, CA
Sponsored by Children's Hospital Los Angeles
Gene Therapy with Etranacogene Dezaparvovec for Hemophilia B.
The New England journal of medicine · 2023 · 303 citations · Guy Young
Nivolumab+AVD in Advanced-Stage Classic Hodgkin's Lymphoma.
The New England journal of medicine · 2024 · 205 citations · Andrew Doan
Revised Neuroblastoma Risk Classification System: A Report From the Children's Oncology Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2021 · 420 citations · Shahab Asgharzadeh
ReNeu: A Pivotal, Phase IIb Trial of Mirdametinib in Adults and Children With Symptomatic Neurofibromatosis Type 1-Associated Plexiform Neurofibroma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2025 · 90 citations · Reuben Antony, Ana Aguilar-Bonilla, Nathan Robison
Emicizumab prophylaxis in infants with hemophilia A (HAVEN 7): primary analysis of a phase 3b open-label trial.
Blood · 2024 · 78 citations · Guy Young
Long-term outcomes with emicizumab prophylaxis for hemophilia A with or without FVIII inhibitors from the HAVEN 1-4 studies.
Blood · 2021 · 242 citations · Guy Young
Current Management of Desmoid Tumors: A Review.
JAMA oncology · 2024 · 86 citations · Fariba Navid
Adolescent and Young Adult (AYA) Oncology, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology.
Journal of the National Comprehensive Cancer Network : JNCCN · 2023 · 146 citations · Marcio Malogolowkin